Breckenridge Announces Appointment of New President
BOCA RATON, Fla., July 10, 2018 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced the appointment of Brian Guy to the position of President. Mr. Guy previously served as Senior Vice President, Business Operations and has been with the company since 2012. Prior to his employment with Breckenridge, Mr. Guy served in senior business development and operations roles in the pharmaceutical industry.
Mr. Guy succeeds Larry Lapila, who retired from his position as President, effective today. Mr. Lapila played a key role in developing and leading Breckenridge since joining in 2001, assuming the role of President in 2014. We thank him for his contributions and wish him much success with his future endeavors.
Breckenridge Pharmaceutical, Inc. is a privately-held own-label distributor that performs pharmaceutical marketing, research and development, as well as marketing and distribution in the U.S. The company was founded in 1983 and markets a broad range of generic prescription products in many therapeutic categories. The Breckenridge label is recognized by wholesalers, distributors, chains, and managed care accounts, as well as retail pharmacies nationwide. The company markets over 70 products in a variety of dosage forms including: tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmics, nasal sprays, powders and injectable products. www.bpirx.com
SOURCE Breckenridge Pharmaceutical, Inc.